triple hormone receptor agonist retatrutide for obesity Explained: How the Actually Works From Obesity to Metabolic Health:

That includes the 1 in 3 Americans who are considered overweight, with a body mass index (BMI) between 25 and 29below the obesity threshold of 30

Mechanistic data on GLP-1R/GIPR/GCGR tri-agonists The combination of GLP-1RA, GIPRA, and GCGRA in preclinical studies has demonstrated superior weight loss relative to liraglutide in mice with diet-induced obesity, attributed to decreased food intake and increased energy expenditure (Baggio & Drucker 2021)

Expression of GLP-1 Receptors in Hypothalamic Areas Regulating Body Temperature in Humans, Journal of Clinical Endocrinology & Metabolism 2

When using semaglutide, a medication often prescribed to manage type 2 diabetes or obesity, specific lifestyle changes can significantly enhance its effectiveness and contribute to improved overall health

What made me interested in trying them is when I read about how the anti-inflammatory properties of the medications arent only possible with weight loss or glycemia